Who
Jonathan Monson
EVP and CFO
Company insider
Files Form 4 as: EVP and CFO, Boston Scientific.
In numbers
- Trades disclosed
- 160
- Buys
- 0
- Sells
- 5
- Bought
- $0
- Sold
- $1.4M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Jul 2019
- Last trade
- 10 Aug 2026
- Last filed
- 11 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Aug 2026filed 11 Aug 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code I | $500K9,908 at $50.46 | filing |
| 10 Aug 2026filed 11 Aug 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code I | $500K9,908 at $50.46 | filing |
| 1 Jul 2026filed 2 Jul 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code M | —2,087 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code F | $43K1,010 at $43.06 | filing |
| 1 Jul 2026filed 2 Jul 2026 | BSX Boston Scientificoption or derivative · Medical Devices | SEC FORM 4 Code M | —2,087 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | BSX Boston Scientificoption or derivative · Medical Devices | SEC FORM 4 Code M | —2,087 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code M | —2,087 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code F | $43K1,010 at $43.06 | filing |
| 16 Feb 2026filed 18 Feb 2026 | BSX Boston Scientificoption or derivative · Medical Devices | SEC FORM 4 Code M | —990 at $0.00 | filing |
| 16 Feb 2026filed 18 Feb 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code M | —990 at $0.00 | filing |
| 16 Feb 2026filed 18 Feb 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code F | $33K440 at $74.73 | filing |
| 16 Feb 2026filed 18 Feb 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code M | —990 at $0.00 | filing |
| 16 Feb 2026filed 18 Feb 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code F | $33K440 at $74.73 | filing |
| 16 Feb 2026filed 18 Feb 2026 | BSX Boston Scientificoption or derivative · Medical Devices | SEC FORM 4 Code M | —990 at $0.00 | filing |
| 14 Feb 2026filed 18 Feb 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code M | —1,058 at $0.00 | filing |
| 14 Feb 2026filed 18 Feb 2026 | BSX Boston Scientificoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,058 at $0.00 | filing |
| 14 Feb 2026filed 18 Feb 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code F | $35K470 at $74.73 | filing |
| 14 Feb 2026filed 18 Feb 2026 | BSX Boston Scientificoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,058 at $0.00 | filing |
| 14 Feb 2026filed 18 Feb 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code M | —1,058 at $0.00 | filing |
| 14 Feb 2026filed 18 Feb 2026 | BSX Boston ScientificMedical Devices | SEC FORM 4 Code F | $35K470 at $74.73 | filing |
News
Boston Scientific Corporation $BSX Stock: Goelzer Investment Management Inc. Raises PositionBSX · dailypolitical.com · 17 Oct 2026Boston Scientific (NYSE:BSX) Upgraded at BarclaysBSX · dailypolitical.com · 10 Oct 2026Financial Contrast: Sysmex (OTCMKTS:SSMXY) and Boston Scientific (NYSE:BSX)BSX · themarketsdaily.com · 10 Oct 2026
0 headlines in the last 90 days name Jonathan Monson; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.